 Matinas BioPharma Holdings, Inc. NYSE AMER: MTNB, a clinical-stage biopharmaceutical company, today commented on the recent United States District Court decision to invalidate patents related to Amarin Corporations Vascepa and also provided an update on the effect of the rapidly evolving COVID-19 